Outset Medical, Inc. (OM)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $4.06
- As of
Kresmion compiles this page from OM's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Outset Medical, Inc. (OM): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-28.
See the full OM dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for OM on one page. Preview it with sample data, then open it live with a free account.
Preview the OM dossierActive signals for OM
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +51% to OM (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 72% of OM (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +491% to OM (2026Q2)
- highINSTITUTIONAL_EXIT
RENAISSANCE TECHNOLOGIES LLC cut 80% of OM (2026Q2)
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 7.9%, EPS $-0.80 vs $-0.7416 estimate
FREE, NO ACCOUNT
Every signal on OM, as it fires
You are seeing 5 of 9 signals recorded on OM since 2026-05-26.
The five above landed across 2 days. The other 4 were recorded on 3 other days. 5 of the 9 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in OM (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 690145206 · 2026Q2 | $785K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 690145206 · 2026Q2 | $188K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 690145206 · 2026Q2 | $48K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, OM
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
OM against its peers
OM's operating margin of -55.8% ranks in the 48th percentile of 23 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-02-28.
| Metric | OM | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 119M USD | 32.0M USD | 90 | 23 |
| Gross margin | 39.1% | 51.7% | 18 | 18 |
| Operating margin | -55.8% | -47.6% | 48 | 23 |
| Net margin | -68.3% | -66.4% | 48 | 23 |
| Return on equity | -64.3% | -86.8% | 63 | 19 |
| 1 year | -67.8% | -31.5% | 17 | 20 |
Peers (23): ZOMDF, LUNG, SERA, MYO, LNSR, HYPR, ECOR, MDNC, POSC, LUCD, MDAI, COCH, TELA, APYX, SNWV, SRTS, XTNT, RPID, OWLT, NNOX, EBRCZ, QTI, QTRX. Left out: RTGN (no annual filing), TLTFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-02-28. Every figure is one full fiscal year read from one annual filing (OM: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow OM on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to OM for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.